Trump's chief of staff, Wiles, was co-chair of lobbying firm, Mercury Public Affairs, in its Florida and Washington, D.C. offices, when it represented Qatar's embassy in the U.S. capital, per ...

Anticipates initiating the Company's Phase 3 accelerated approval trial of IFx-Hu2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy for ...